Skip to content
Open access · OA via Europe PMC

Impact of frailty phenotype on chronic disease accumulation and healthy life years lost: A multi-state analysis of the UK Biobank.

Xing X, Zhao C, Li M, Huang J, Chen Y, Sun W, Yu Y, Chen X, Qiao L, Li Y, Yan X, Li Y.

The journal of nutrition, health & aging · 2026

Abstract

<h4>Background</h4>Frailty is a systemic vulnerability syndrome linked to adverse health outcomes, yet its role in shaping the dynamic trajectory from health through incident disease to multimorbidity remains poorly understood.<h4>Methods</h4>Among 276,696 disease-free UK Biobank participants (mean age 55.3 years; 53.5% female; median follow-up of over 13 years), we evaluated baseline frailty phenotype (robust, pre-frail, frail) as a predictor of 43 chronic conditions using Cox models and restricted mean survival time (RMST) analysis. A four-state Markov multistate model mapped transitions across healthy, incident disease, multimorbidity, and death. Multimorbidity clustering was performed via multiple correspondence analysis and K-means. Population attributable fractions (PAFs) quantified the frailty-attributable disease burden.<h4>Results</h4>Frailty was significantly associated with 42 of 43 conditions (97.7%). The frail group lost 2.72 years (95% CI, 2.64-2.81) of multimorbidity-free survival over 12 years. In multistate models, frailty was strongly associated with higher hazards of transition from healthy to incident disease (HR 1.77; 95% CI, 1.72-1.83) and from incident disease to multimorbidity (HR 1.73; 95% CI, 1.68-1.79), but showed attenuated associations with post-disease mortality. Four stable multimorbidity phenotypes were identified. PAF analysis indicated that eliminating pre-frailty and frailty could theoretically prevent 9.85% of incident disease events and 9.40% of multimorbidity progression, with pre-frailty contributing the majority of the attributable burden (7.83%).<h4>Conclusions</h4>Baseline frailty was strongly associated with broad-spectrum chronic disease onset and accelerated multimorbidity accumulation. Systematic screening and early intervention targeting pre-frailty, particularly in middle-aged populations, holds substantial promise for delaying the multimorbidity trajectory.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.1016/j.jnha.2026.100967
Canonical
link ↗
Fetched
2026-10-09 MST

Cite this

APA
X, X., C, Z., M, L., J, H., Y, C., W, S., Y, Y., X, C., L, Q., Y, L., X, Y., &amp; Y., L. (2026). Impact of frailty phenotype on chronic disease accumulation and healthy life years lost: A multi-state analysis of the UK Biobank. <em>The journal of nutrition, health & aging</em>. https://doi.org/10.1016/j.jnha.2026.100967
Vancouver
X X, C Z, M L, J H, Y C, W S, et al. Impact of frailty phenotype on chronic disease accumulation and healthy life years lost: A multi-state analysis of the UK Biobank. The journal of nutrition, health & aging. 2026. doi:10.1016/j.jnha.2026.100967.
BibTeX
@article{xing2026Impact, title = {Impact of frailty phenotype on chronic disease accumulation and healthy life years lost: A multi-state analysis of the UK Biobank.}, author = {Xing X and Zhao C and Li M and Huang J and Chen Y and Sun W and Yu Y and Chen X and Qiao L and Li Y and Yan X and Li Y.}, journal = {The journal of nutrition, health & aging}, year = {2026}, doi = {10.1016/j.jnha.2026.100967}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings